Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Scottsdale, Arizona 85258


Purpose:

The IPTLD QoL Broad Study.


Study summary:

A Quality of Life Study Using Insulin Potentiation Targeted LowDose (IPTLD) Chemotherapy and Nutrition Therapy in the Treatment of Cancer.


Criteria:

Inclusion Criteria: - diagnosis of cancer, - age older than 18 years, - requesting IPTLD and nutrition therapy Exclusion Criteria: - diagnosis other than cancer, - age younger than 18 years, - requesting conventional chemotherapy


Study is Available At:


Original ID:

Protocol V1- 08-12-2015


NCT ID:

NCT02598479


Secondary ID:


Study Acronym:

IPTLDAZCAM


Brief Title:

A Quality of Life Study Using Insulin Potentiation Targeted LowDose (IPTLD) Chemotherapy and Nutrition Therapy in the Treatment of Cancer


Official Title:

The IPTLD QoL Broad Study A Quality of Life Study Using Insulin Potentiation Targeted LowDose (IPTLD) Chemotherapy and Nutrition Therapy in the Treatment of Cancer


Overall Status:

Withdrawn


Study Phase:

N/A


Genders:

N/A


Minimum Age:

18 Years


Maximum Age:

N/A


Quick Facts

Healthy Volunteers
Oversight Has DMC
Study Is FDA Regulated
Study Is Section 801
Has Expanded Access

Study Source:

Best Answer for Cancer Foundation


Oversight Authority:

United States: Food and Drug Administration


Reasons Why Stopped:

The IRB which was overseeing the study stopp


Study Type:

Observational


Study Design:


Number of Arms:

0


Number of Groups:

1


Total Enrollment:

0


Enrollment Type:

Actual


Overall Contact Information

Official Name:Martha M Grout, MD, MD(H)
Principal Investigator
Arizona Center for Advanced Medicine

Study Dates

Start Date:November 2015
Completion Date:August 2018
Completion Type:Actual
Primary Completion Date:August 2018
Primary Completion Type:Actual
Verification Date:August 2018
Last Changed Date:August 27, 2018
First Received Date:November 4, 2015

Study Outcomes

Outcome Type:Primary Outcome
Measure:Improvement in Quality of Life measured by questionnaires
Time Frame:5 years
Safety Issues:False
Description:Improvement in Quality of Life using Insulin Potentiation Low Dose Chemotherapy and Nutrition Therapy for the Treatment of Cancer, as measured by MD Anderson's MDASI questionnaires

Study Interventions

Intervention Type:Other
Name:IPTLD and nutrition therapy
Description:The measurement of Quality of Life in patients who choose to use Insulin Potentiation Low Dose Therapy and Nutritional Therapy in the treatment of cancer
Arm Name:IPTLD and nutrition therapy

Study Arms

Study Arm Type:Other
Arm Name:IPTLD and nutrition therapy
Description:Patients presenting to the Arizona Center for Advanced Medicine for the treatment of cancer using Insulin Potentiation Low Dose Chemotherapy and Nutrition Therapy

Study Agencies

Agency Class:Other
Agency Type:Lead Sponsor
Agency Name:Best Answer for Cancer Foundation

Samples and Retentions

Study Population: Patients over the age of 18 who have chosen to receive IPTLD with nutrition therapy
Sample Method:Non-Probability Sample

Study References

There are no available Study References

Data Source: ClinicalTrials.gov

Date Processed: January 21, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


This study is not currently recruiting Study Participants. The form below is not enabled.